For this reason, a radiolabelled version of IL-2 ([99mTc]Tc-IL2) has been developed and used to detect in vivo the presence of activated organ-infiltrating lymphocytes, and in particular those expressing cluster designation (CD) 25 antigen (IL-2 receptor [IL2R]) in melanoma patients undergoing surgical treatment [83]. Here, IL2 is linked to melanoma.